REATA PHARMACEUTICALS INC Deferred Offering Costs
REATA PHARMACEUTICALS INC had Deferred Offering Costs of $404.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-02.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2018-03-02
- 2017-12-31: Deferred Offering Costs $404.00K.
- 2017-08-01: Deferred Offering Costs $386.00K.
- 2016-12-31: Deferred Offering Costs $3.47M; Deferred Offering Costs as first filed $0.00.
- 2016-06-30: Deferred Offering Costs $3.49M.
| Period end | Deferred Offering Costs | Deferred Offering Costs as first filed |
|---|---|---|
| 2017-12-31 | $404.00K 10-K · filed 2018-03-02 | |
| 2017-08-01 | $386.00K 10-Q · filed 2017-11-13 | |
| 2016-12-31 | $3.47M 10-K · filed 2018-03-02 | $0.00 10-K · filed 2017-03-03 |
| 2016-06-30 | $3.49M 10-Q · filed 2016-08-11 | |
| 2016-06-01 | $3.49M 10-Q · filed 2017-11-13 | |
| 2015-12-31 | $1.99M 10-K · filed 2017-03-03 |